Mucoadhesive microspheres containing gentamicin sulfate for nasal administration: Preparation and in vitro characterization

Farmaco

Volumn 58, Issue 1, 2003, Pages 11-16

  Hasçiçek, Canan ^a   Gönül, Nurşin ^a   Erk, Nevin ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Gentamicin sulfate; Hydroxypropyl methylcellulose; Mucoadhesive microspheres; Nasal drug delivery; Sodium cholate; Spray drying

Indexed keywords

CHOLIC ACID; GENTAMICIN; HYDROXYMETHYLCELLULOSE; MICROSPHERE; POLYMER; ADHESIVE AGENT;

ADHESION; ARTICLE; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG SYNTHESIS; ENCAPSULATION; EVALUATION; IN VITRO STUDY; NOSE MUCOSA; PARTICLE SIZE; SPRAY DRYING; SURFACE PROPERTY; INTRANASAL DRUG ADMINISTRATION; METHODOLOGY; PHARMACEUTICS; SYNTHESIS;

ADHESIVES; ADMINISTRATION, INTRANASAL; GENTAMICINS; MICROSPHERES; TECHNOLOGY, PHARMACEUTICAL;

EID: 0041967089     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(02)00004-6     Document Type: Article

References (29)

1. Cornaz A., Buri P. Nasal mucosa as an absorption barrier. Eur. J. Pharm. Biopharm. 40:1994;261-270.
2. Muggetti L., Zurlo M., Martini A., Civaroli P., De Ponti R. Preformulation activities of intranasal dosage forms of temazepam. Int. J. Pharm. 136:1996;81-88.
3. Vidgren P., Vidgren M., Vainio P., Nuutinen J., Paronen P. Double-labelling technique in the evaluation of nasal mucoadhesion of disodium cromoglycate microspheres. Int. J. Pharm. 73:1991;131-136.
4. Ugwoke M.I., Kaufmann G., Verbeke N., Kinget R. Intranasal bioavability of apomorphine from carboxymethylcellulose-based drug delivery systems. Int. J. Pharm. 202:2000;125-131.
5. Illum L., Jorgensen H., Bisgaard H., Krogsgoard O., Rossing N. Bioadhesive microspheres as a potential nasal drug delivery system. Int. J. Pharm. 39:1987;189-199.
6. Vidgren P., Vidgren M., Arppe J., Hakuli T., Laine E., Paronen P. In vitro evaluation of spray-dried mucoadhesive microspheres for nasal administration. Drug. Dev. Ind. Pharm. 18:1992;581-597.
7. Nakamura F., Ohta R., Machida Y., Nagai T. In vitro and in vivo nasal mucoadhesion of some water-soluble polymers. Int. J. Pharm. 134:1996;173-181.
8. Zhou M., Donovan M.D. Intranasal mucociliar clearance of putative bioadhesive polymer gels. Int. J. Pharm. 135:1996;115-125.
9. Illum L., Farraj N., Critchley H., Davis S.S. Nasal administration of gentamicin using a novel microsphere delivery system. Int. J. Pharm. 46:1988;261-265.
10. Björk E., Edman P. Characterization of degradable starch microspheres as a nasal delivery system for drugs. Int. J. Pharm. 62:1990;187-192.
11. Dondeti P., Zia H., Needham T.E. Bioadhesive and formulation parameters affecting nasal absorption. Int. J. Pharm. 127:1996;115-133.
12. Merkus F.W.H.M., Schipper N.G.M., Hermens W.A.J.J., Romeijn S.G., Verhoef J.C. Absorption enhancers in nasal drug delivery: efficacy and safety. J. Controlled Release. 24:1993;201-208.
13. Illum L., Fisher A.N., Jabbal-Gill I., Davis S.S. Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides. Int. J. Pharm. 222:2001;109-119.
14. Farraj N.F., Johansen B.R., Davis S.S., Illum L. Nasal administration of insulin using bioadhesive microspheres as a delivery system. J. Controlled Release. 13:1990;253-261.
15. Verhoef J.C., Schipper N.G.M., Romeijn S.G., Merkus F.W.H.M. The potential of cyclodextrins as absorption enhancers in nasal delivery of peptide drugs. J. Controlled Release. 29:1994;351-360.
16. Behl C.R., Pimplaskar H.K., Sileno A.P., Xia W.J., Gries W.J., Demeireles J.C., Romeo V.D. Optimization of systemic nasal drug delivery with pharmaceutical excipients. Adv. Drug. Deliv. Rev. 29:1998;117-133.
17. Duchateau G.S.M.J.E., Zuidema J., Merkus F.W.H.M. Bile salts and intranasal drug absorption. Int. J. Pharm. 31:1986;193-199.
18. C. Ogan-Hasçiçek, N. Gönül, Preparation and characterization of bioadhesive microspheres for nasal administration,12th International Symposium on Microencapsulation, London, 6-8 September 1999, Abstract book, p. 29.
19. Rango Rao K.V., Buri P. A novel in situ method to test polymers and coated microparticles for bioadhesion. Int. J. Pharm. 52:1989;265-270.
20. Vyas S.P., Talwar N., Karajgi J.S., Jain N.K. An erythrocyte based bioadhesive system for nasal delivery of propranolol. J. Controlled Release. 23:1993;231-237.
21. Abd El-Hameed M.D., Kellaway I.W. Preparation and in vitro characterisation of mucoadhesive polymeric microspheres as intra-nasal delivery systems. Eur. J. Pharm. Biopharm. 44:1997;53-60.
22. İ. Agabeyoglu, Un programme dans la language basique de microcomputer pour la determination des donnees de dissolution, XVIII Semaine Medicale Balkanique, İstanbul, 30 August-4 September c, p. 327.
23. Conte U., Giunchedi P., Maggi L., Torre M.L. Spray dried albumin microspheres containing nicardipine. Eur. J. Pharm. Biopharm. 40:1994;203-208.
24. Pavanetto F., Conti B., Genta I., Giunchedi P. Solvent evaporation, solvent extraction and spray drying for polylactide microsphere preparation. Int. J. Pharm. 84:1992;151-159.
25. Conte U., Conti B., Giunchedi P., Maggi L. Spray dried polylactide microsphere preparation: influence of the technological parameters. Drug. Dev. Ind. Pharm. 20:1994;235-258.
26. Chien W.Y., Su S.K., Chang F.S. Nasal Systemic Drug Delivery. 1989;63-67 Marcel Dekker, New York.
27. The Merk Index, 13th ed., 2001, pp. 780-781.
28. The Martindale, 32nd ed., 1999, p. 212.
29. Lim S.T., Martin G.P., Berry D.J., Brown M.B. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J. Controlled Release. 66:2000;281-292.